Patent · US Active

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

US10407441B2 · kind B2 · utility

9Cited by
36References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2018
Grant dateSep 10, 2019
Priority date
Expiry dateFeb 1, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features compositions and methods for treating or preventing a neoplasia. More specifically, the invention provides compositions and methods for disrupting the interaction of a BET family polypeptide comprising a bromodomain with chromatin (e.g., disrupting a bromodomain interaction with an acetyl-lysine modification present on a histone N-terminal tail).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.